Oxidizing agents as systemic (parenteral) pharmaceuticals

Details Oxidizing agents as systemic (parenteral) pharmaceuticals Oxidizing agents as systemic (parenteral) pharmaceuticals

A - Human Necessities

61

K

A61K 31/13 (2006.01) A61K 31/00 (2006.01) A61K 31/18 (2006.01)

Patent

CA 2017987

- 1 - Abstract of the disclosure: Oxidizing agents as systemic (parenteral) pharmaceuticals A description is given of how oxidizing agents, especi- ally oxidizing agents selective for methionine, can be used as systemic (parenteral) pharmaceuticals, especially for anticoagulation and fibrinolysis or immunostimula- tion.

Affiliated with

Also associated with

Rating

Oxidizing agents as systemic (parenteral) pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxidizing agents as systemic (parenteral) pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxidizing agents as systemic (parenteral) pharmaceuticals will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1869270